Kidney Cancer
Prostate Cancer
EAU Edu Platform on Bladder Cancer
Home
Articles
Article of the Month
Editorial
Videos
Webcasts
Education
E-courses
Webinars
ESOU Online
Clinical problems
Guidelines
Events
Home
Articles
Terug
Article of the Month
Editorial
Videos
Webcasts
Education
Terug
E-courses
Webinars
ESOU Online
Clinical problems
Guidelines
Events
Upcoming event
ESU-ESOU Masterclass on Muscle-invasive bladder cancer
Home
/
Videos
Back
EAU23
ASCO GU23
EMUC2022
ESMO2022
EAU22
ASCO GU22
EMUC21
EAU 21
ESOU 21
ASCO GU21
EAU20
ESOU Online
ASCO19
EAU19
GU19
EMUC 2018
Surgery
EMUC 2014
ESMO 2014
ERUS 2014
Filter
Tags
5-α reductase inhibitors
,
Androgen antagonists
,
Article of the Month
,
ASCO GU21
,
ASCO GU22
,
ASCO21
,
AUA21
,
BCG
,
BCG therapy
,
BCG-unresponsive disease
,
Bladder neoplasms
,
Bladder-sparing therapy
,
Bladder-sparing trimodality
,
Chemoradiotherapy
,
Clinical pathways
,
Clinical staging
,
Collaborative care
,
Comorbidity
,
Cystectomy
,
Early recurrence patterns
,
EAU21
,
EAU22
,
EMUC21
,
EMUC22
,
EORTC
,
ERBB2
,
ERCC2
,
ESMO21
,
ESOU21
,
ESOU22
,
Gene expression analysis
,
Guidelines
,
Hematuria
,
High-risk NMIBC
,
Highlight of the Month
,
Immune checkpoint
,
Immune checkpoint blockade
,
Immunoregulation
,
Immunotherapy
,
Intravesical therapy
,
Laparoscopic radical cystectomy
,
Masterclass
,
Masterclass on MIBC
,
Masterclass on NMIBC
,
Meta-analysis
,
Metastatic urothelial cancer
,
MIBC
,
Microscopic haematuria
,
Molecular subtypes
,
Multiparametric MRI
,
Neoadjuvant
,
Neoadjuvant chemotherapy
,
Neoplasm recurrence
,
Nephroureterectomy
,
NIBC
,
Non-visible haematuria
,
Nuclear matrix protein 22
,
Oncologic outcomes
,
Open radical cystectomy
,
Optical coherence
,
PD-L1
,
Pembrolizumab
,
PET
,
PLND
,
Postoperative complications
,
POUT trial
,
Prevention & control
,
Quality of life
,
Radical cystectomy
,
Radio-chemotherapy
,
Randomized controlled trial
,
RARC
,
RAZOR Trial
,
Recurrence
,
Robotic
,
Robotic prostatectomy
,
Robotic radical cystectomy
,
Robotic surgery
,
Surgical video
,
Surgical videos
,
Systematic review
,
Tomography
,
Transitional cell
,
Transitional cell carcinoma
,
Tregs
,
Urinary bladder neoplasms
,
Urinary diversion
,
Urological surgery
,
Urothelial cancer
,
Urothelium
,
UROwebinar
,
UTUC
,
Webinar
Show all
BAYOU study
Watch now
Circulating tumour DNA for decision making in high risk and metastatic bladder cancer
Watch now
Radio-immunotherapy for bladder preservation
Watch now
NABUCCO trial (cohort 2)
Watch now
Urine biomarkers for diagnosis and follow-up/recurrence
Watch now
Does every metastatic patient need immunotherapy in a first-line setting?
Watch now
Pembro in combination with Gem and concurrent hypofractionated RT as bladder sparing treatment for MIBC
Watch now
Phase-2 trial of gemcitabine, cisplatin + nivolumab with selective bladder sparing in MIBC patients
Watch now
A phase Ib single-arm study of bintrafusp alfa
Watch now
Optimal therapy is intravesical
Watch now
State of the Art lecture – Developments in metastatic urothelial cancer
Watch now
Clinical case – Extend the benefit of immuno-oncology to more MIBC patients: How do we do better?
Watch now
Previous
Next